Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group.

Le Maître, Aurélie

Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer May 2009 - 586-94 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1556-1380

10.1097/JTO.0b013e31819f9a8a doi


Aged
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Anticoagulants--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Female
Hemorrhage--chemically induced
Heparin, Low-Molecular-Weight--administration & dosage
Humans
Lung Diseases--chemically induced
Lung Neoplasms--drug therapy
Male
Prognosis
Randomized Controlled Trials as Topic
Retrospective Studies
Risk Factors
Venous Thromboembolism--chemically induced
Warfarin--administration & dosage